Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-13

Clinical Trial Update: Hybrid L24 New Enrollment Post Approval Study [NA]

View source ↗

Summary

Clinical trial update for a post-approval study related to high frequency sensorineural hearing loss; study status completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cochlear

Snippet

Sponsor: Cochlear | Conditions: High Frequency Sensorineural Hearing Loss | NA | Status: COMPLETED | Results posted: 2023-03-13